Merck Serono, a division of Merck KgaA Darmstadt, Germany, announced that the Japanese health authorities, the Pharmaceutical and Medical Devices Agency (PMDA), have granted a marketing authorization for easypod in Japan. Easypod was developed for exclusive use with cartridges of Saizen (somatropin), Merck Serono's human recombinant growth hormone for the treatment of growth hormone deficiency.
The details can be read here.
No comments:
Post a Comment